These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 20066897)

  • 1. Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.
    Wong SW; Tiong KH; Kong WY; Yue YC; Chua CH; Lim JY; Lee CY; Quah SI; Fow C; Chung C; So I; Tan BS; Choo HL; Rosli R; Cheong SK; Leong CO
    Breast Cancer Res Treat; 2011 Jul; 128(2):301-13. PubMed ID: 20686837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin potentiates cytotoxicity by docetaxel possibly through downregulation of Survivin in lung cancer cells.
    Niu H; Wang J; Li H; He P
    J Exp Clin Cancer Res; 2011 Mar; 30(1):28. PubMed ID: 21392382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of chemotherapy with cisplatin and rapamycin against Hep-2 cells in vitro].
    Lei WB; Jia T; Su ZZ; Wen WP; Zhu XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1838-41. PubMed ID: 18971185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
    Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA
    BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of mammalian target of rapamycin (mTOR) signaling pathway inhibits proliferation and induces apoptosis of laryngeal carcinoma cells in vitro.
    Li R; Wang R; Zhai R; Dong Z
    Tumori; 2011; 97(6):781-6. PubMed ID: 22322846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.
    Liu J; Zhang L; Zhang X; Xing X
    J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of rapamycin and cisplatin on survival of Hep-2 cells in vitro.
    Lei W; Jia T; Su Z; Wen W; Zhu X
    Oncol Res; 2009; 18(2-3):73-81. PubMed ID: 20066897
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.